• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基胍不能抑制大鼠实验性糖尿病视网膜病变的初始阶段。

Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

作者信息

Hammes H P, Ali S S, Uhlmann M, Weiss A, Federlin K, Geisen K, Brownlee M

机构信息

Third Medical Department, Justus-Liebig-University of Giessen, Germany.

出版信息

Diabetologia. 1995 Mar;38(3):269-73. doi: 10.1007/BF00400629.

DOI:10.1007/BF00400629
PMID:7758871
Abstract

We have previously shown that long-term administration of aminoguanidine, an inhibitor of advanced glycosylation product formation, reduces the extent of experimental diabetic retinopathy in the rat by 85%. In order to determine whether the residual retinopathy that developed despite aminoguanidine was attributable to advanced glycation endproduct formation, a time-course study was performed in three different groups of male Wistar rats: non-diabetic controls (NC), streptozotocin-diabetic controls (DC) and streptozotocin-diabetic rats treated with aminoguanidine HCL, 50 mg/100 ml drinking water (D-AG). Eyes were obtained at 24, 32, 44 and 56 weeks of diabetes/treatment duration and morphologic evaluation was done on retinal digest preparations. At 56 weeks, retinal basement membrane thickness was additionally measured. After 24 weeks of diabetes, the number of acellular capillaries was significantly elevated in DC (44.6 +/- 5.7/mm2 of retinal area, NC 19.6 +/- 4.9; p < 0.001) and increased continuously over time (DC 56 weeks 87.4 +/- 15.1; p < 0.001 vs DC24 weeks). In contrast, acellular capillaries in D-AG increased over the first 24 weeks and then remained constant for the rest of the study (D-AG 24 weeks 35.7 +/- 5.18; p < 0.01 vs NC 24 weeks and NS vs DC 24 weeks; D-AG 56 weeks 42.0 +/- 6.20; p NS vs D-AG 24 weeks).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们之前已经表明,长期给予氨基胍(一种晚期糖基化产物形成抑制剂)可使大鼠实验性糖尿病视网膜病变的程度降低85%。为了确定尽管使用了氨基胍仍发生的残余视网膜病变是否归因于晚期糖基化终产物的形成,我们对三组不同的雄性Wistar大鼠进行了一项时间进程研究:非糖尿病对照组(NC)、链脲佐菌素诱导的糖尿病对照组(DC)以及用盐酸氨基胍(50 mg/100 ml饮用水)治疗的链脲佐菌素诱导的糖尿病大鼠(D - AG)。在糖尿病/治疗持续24、32、44和56周时获取眼睛,并对视网膜消化制剂进行形态学评估。在56周时,还额外测量了视网膜基底膜厚度。糖尿病24周后,DC组无细胞毛细血管数量显著增加(每平方毫米视网膜面积44.6±5.7个,NC组为19.6±4.9个;p<0.001),且随时间持续增加(DC组56周时为87.4±15.1个;与DC组24周相比,p<0.001)。相比之下,D - AG组无细胞毛细血管在最初24周增加,然后在研究的其余时间保持稳定(D - AG组24周时为35.7±5.18个;与NC组24周相比,p<0.01,与DC组24周相比无显著差异;D - AG组56周时为42.0±6.20个;与D - AG组24周相比无显著差异)。(摘要截断于250字)

相似文献

1
Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.氨基胍不能抑制大鼠实验性糖尿病视网膜病变的初始阶段。
Diabetologia. 1995 Mar;38(3):269-73. doi: 10.1007/BF00400629.
2
Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.在大鼠模型中,用氨基胍进行二次干预可延缓糖尿病性视网膜病变的进展。
Diabetologia. 1995 Jun;38(6):656-60. doi: 10.1007/BF00401835.
3
Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.氨基胍可抑制自发性高血压大鼠加速型糖尿病视网膜病变的发展。
Diabetologia. 1994 Jan;37(1):32-5. doi: 10.1007/BF00428774.
4
Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.抑制糖基化和氧化应激对糖尿病大鼠白内障和视网膜血管异常发展的影响。
Curr Eye Res. 2000 Jul;21(1):543-9.
5
Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.抑制晚期糖基化终产物可预防长期糖尿病期间视网膜毛细血管基底膜扩张。
J Pathol. 2003 Oct;201(2):328-33. doi: 10.1002/path.1429.
6
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.氨基胍治疗可抑制实验性糖尿病视网膜病变的发展。
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8. doi: 10.1073/pnas.88.24.11555.
7
Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.糖尿病视网膜中含一氧化氮合酶神经元的耗竭:氨基胍的逆转作用。
Diabetologia. 1998 Dec;41(12):1419-25. doi: 10.1007/s001250051087.
8
Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.胍类化合物对糖尿病大鼠肾脏结构与功能、局部血管功能障碍及胶原变化的不一致影响。
Diabetes. 1997 Jan;46(1):94-106. doi: 10.2337/diab.46.1.94.
9
Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.ω-3脂肪酸加速大鼠实验性糖尿病视网膜病变
Diabetologia. 1996 Mar;39(3):251-5. doi: 10.1007/BF00418338.
10
The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.氨基胍对链脲佐菌素诱导的糖尿病大鼠视网膜病变的影响。
Bioorg Med Chem Lett. 2012 Jul 1;22(13):4386-90. doi: 10.1016/j.bmcl.2012.04.130. Epub 2012 May 9.

引用本文的文献

1
Oxidative Stress and Its Regulation in Diabetic Retinopathy.氧化应激及其在糖尿病视网膜病变中的调节
Antioxidants (Basel). 2023 Aug 21;12(8):1649. doi: 10.3390/antiox12081649.
2
Connective tissue growth factor is involved in structural retinal vascular changes in long-term experimental diabetes.结缔组织生长因子参与长期实验性糖尿病中的结构性视网膜血管改变。
J Histochem Cytochem. 2014 Feb;62(2):109-18. doi: 10.1369/0022155413512656. Epub 2013 Nov 11.
3
Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

本文引用的文献

1
Studies of retinal vascular patterns. I. Normal architecture.视网膜血管模式研究。I. 正常结构
Arch Ophthalmol. 1960 Dec;64:904-11. doi: 10.1001/archopht.1960.01840010906012.
2
Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.葡萄糖对胶原蛋白的糖基化、糖氧化及交联作用。美拉德反应后期的动力学、机制及抑制作用。
Diabetes. 1994 May;43(5):676-83. doi: 10.2337/diab.43.5.676.
3
Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.
三种糖尿病大鼠品系在视网膜病变和触觉异常性疼痛发生速率方面的比较。
Mol Vis. 2010 Aug 15;16:1629-39.
4
Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.链脲佐菌素诱导的糖尿病大鼠视网膜中光感受器的凋亡性死亡。
Diabetologia. 2003 Sep;46(9):1260-8. doi: 10.1007/s00125-003-1177-6. Epub 2003 Jul 31.
5
Advanced glycation: an important pathological event in diabetic and age related ocular disease.晚期糖基化:糖尿病及年龄相关性眼病中的一个重要病理事件。
Br J Ophthalmol. 2001 Jun;85(6):746-53. doi: 10.1136/bjo.85.6.746.
6
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.晚期糖基化终末产物(AGEs)与糖尿病大鼠及注射AGE的大鼠视网膜血管中的AGE受体共定位。
Am J Pathol. 1997 Feb;150(2):523-31.
氨基胍可抑制自发性高血压大鼠加速型糖尿病视网膜病变的发展。
Diabetologia. 1994 Jan;37(1):32-5. doi: 10.1007/BF00428774.
4
Kinetic analysis of the nonenzymatic glycosylation of hemoglobin.血红蛋白非酶糖基化的动力学分析。
J Biol Chem. 1981 May 25;256(10):5204-8.
5
Structure of basement membrane in normal and diabetic tissue.正常组织和糖尿病组织中基底膜的结构。
Ann N Y Acad Sci. 1982;401:203-11. doi: 10.1111/j.1749-6632.1982.tb25719.x.
6
Glucosylation of human haemoglobin a in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c.体外研究红细胞中人血红蛋白a的糖基化。血红蛋白A1c形成和解离的动力学。
Clin Chim Acta. 1983 Nov 15;134(3):317-26. doi: 10.1016/0009-8981(83)90370-4.
7
Nonenzymatic glycosylation and the pathogenesis of diabetic complications.非酶糖基化与糖尿病并发症的发病机制
Ann Intern Med. 1984 Oct;101(4):527-37. doi: 10.7326/0003-4819-101-4-527.
8
Angioarchitecture of the pancreas of the cat. Light-, scanning- and transmission electron microscopy.猫胰腺的血管构筑。光镜、扫描电镜和透射电镜观察
Cell Tissue Res. 1984;235(3):675-82. doi: 10.1007/BF00226968.
9
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.威斯康星糖尿病视网膜病变流行病学研究。II. 诊断时年龄小于30岁的糖尿病视网膜病变患病率及风险
Arch Ophthalmol. 1984 Apr;102(4):520-6. doi: 10.1001/archopht.1984.01040030398010.
10
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein.胶原蛋白上的非酶糖基化产物会共价捕获低密度脂蛋白。
Diabetes. 1985 Sep;34(9):938-41. doi: 10.2337/diab.34.9.938.